140 related articles for article (PubMed ID: 37088654)
1. A rare primary large-cell neuroendocrine carcinoma of the prostate: A case report.
Li Y; Chen Y; Cai Y; Sandeep B
Asian J Surg; 2023 Sep; 46(9):3930-3931. PubMed ID: 37088654
[No Abstract] [Full Text] [Related]
2. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
Tzou KY; Cheng WH; Lee WH; Ho CH
J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
[TBL] [Abstract][Full Text] [Related]
3. Metastatic large-cell neuroendocrine prostate carcinoma: successful treatment with androgen deprivation therapy.
Azad AA; Jones EC; Chi KN
Clin Genitourin Cancer; 2014 Aug; 12(4):e151-3. PubMed ID: 24787970
[No Abstract] [Full Text] [Related]
4. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.
Aparicio A; Tzelepi V; Araujo JC; Guo CC; Liang S; Troncoso P; Logothetis CJ; Navone NM; Maity SN
Prostate; 2011 Jun; 71(8):846-56. PubMed ID: 21456067
[TBL] [Abstract][Full Text] [Related]
6. Primary Prostatic Carcinoma With De Novo Diffuse Neuroendocrine Differentiation.
Galea LA; Mow C; Fine SW; Manohar P
Int J Surg Pathol; 2022 Apr; 30(2):232-236. PubMed ID: 34338584
[TBL] [Abstract][Full Text] [Related]
7. A rare case of large cell neuroendocrine carcinoma.
Lin D; Tan AJ; De Sousa AF; Singh-Rai R
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25331150
[TBL] [Abstract][Full Text] [Related]
8. Large-cell neuroendocrine carcinoma of prostate. Case report.
Moratalla Charcos LM; Pastor Navarro T; Cortes Vizcaino V; Osca Garcia JM; Gil Salom M
Arch Esp Urol; 2013 May; 66(4):368-71. PubMed ID: 23676541
[TBL] [Abstract][Full Text] [Related]
9. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
Romero-Rojas AE; Diaz-Perez JA; Reddy A
Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
Matsumoto Y; Mibu H; Kagebayashi Y
Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
[TBL] [Abstract][Full Text] [Related]
11. Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
Sleiman W; Karray O; Abi Abdallah M; Bleichner-Perez S; Kourda J; Cosma-Opris M; Assouad S; Riffaud JC; Bart S; Coloby P
J Med Case Rep; 2021 May; 15(1):254. PubMed ID: 33957979
[TBL] [Abstract][Full Text] [Related]
12. Primary Large Cell Neuroendocrine Carcinoma of the Parotid Gland. Report of a Rare Case.
Tosios KI; Papanikolaou V; Vlachodimitropoulos D; Goutas N
Head Neck Pathol; 2021 Dec; 15(4):1377-1384. PubMed ID: 33544384
[TBL] [Abstract][Full Text] [Related]
13. The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.
Pósfai B; Kuthi L; Varga L; Laczó I; Révész J; Kránicz R; Maráz A
Anticancer Res; 2018 Jun; 38(6):3243-3254. PubMed ID: 29848671
[TBL] [Abstract][Full Text] [Related]
14. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
[TBL] [Abstract][Full Text] [Related]
15. Recurrent prostate carcinoma presenting as omental large cell carcinoma with neuroendocrine differentiation and resulting in bowel obstruction.
Wynn SS; Nagabundi S; Koo J; Chin NW
Arch Pathol Lab Med; 2000 Jul; 124(7):1074-6. PubMed ID: 10888786
[TBL] [Abstract][Full Text] [Related]
16. [Management of neuroendocrine prostate carcinoma: Literature review].
Yossi S; Brahmi T; Enachescu C; Selmaji I; Lapierre A; Samlali H; Chapet O
Cancer Radiother; 2016 Jun; 20(4):330-5. PubMed ID: 27340027
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine carcinoma of prostate presenting with ascites.
Sagar N; Kushwaha P; Mallya V; Jain S; Khurana N; Hadke NS
J Cancer Res Ther; 2021; 17(2):577-579. PubMed ID: 34121712
[TBL] [Abstract][Full Text] [Related]
18. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
[TBL] [Abstract][Full Text] [Related]
19. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
[TBL] [Abstract][Full Text] [Related]
20. [Neuroendocrine differentiation and metastasized to brain stem, intraorbit and base of tongue in prostate cancer during hormonal treatment: a case report].
Sugi M; Yanishi M; Shimada O; Kawakita S; Murota T; Shikata N
Hinyokika Kiyo; 2008 May; 54(5):373-6. PubMed ID: 18546865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
